December 2020
SAFETY OBSERVER N173
20 PAGES
EU Clinical Trial Regulation
New FDA Draft Guidance
PV in the COVID-19 era
Product Safety News
PUBLICATIONS / NUMBER 173
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Back issues
Latest ReleaseSafety Observer 175Draft GVP Module XVI on RMMs
EMA CTIS Training
Post-Brexit Guidance
Canada ADR Reporting guidance
And more...
Safety Observer 173EU Clinical Trial Regulation
New FDA Draft Guidance
PV in the COVID-19 era
Product Safety News
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
